Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (...
Saved in:
Main Authors: | Jianbo He, Hong Wang, Ying Liu, Wen Li, Dorothy Kim, Hu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2015/605946 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
by: Hui-Jin Chen, et al.
Published: (2019-01-01) -
Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension
by: Carmine Savoia, et al.
Published: (2011-01-01) -
Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy
by: Byung Ju Jung, et al.
Published: (2019-01-01) -
Three Cases of Organized Hematoma of the Maxillary Sinus: Clinical Features and Immunohistological Studies for Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 Expressions
by: Shoichiro Imayoshi, et al.
Published: (2015-01-01) -
Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
by: Xuting Chen, et al.
Published: (2019-01-01)